Changchun hi tech: growth hormone is a prescription drug, which is sold to medical institutions that meet the requirements of laws and regulations
Changchun hi tech said on the interactive platform that the company produces and operates in strict accordance with the requirements of laws and regulations. Growth hormone is a prescription drug. The state has strict laws and regulations on the sales of growth hormone, such as the drug administration law and the Anti Doping regulations. Relevant products are sold to medical institutions that meet the requirements of laws and regulations. For the use of growth hormone products, doctors need to carry out a series of rigorous testing items, including growth hormone stimulation test, before prescribing according to the specific situation and clinical requirements of the disease.
This text is a result of machine translation.
Related companies：
Briefing Jun 20, 2022 04:54 PM
· Technology
The official results of the French parliamentary elections were announced, and the ruling party coalition held a relatively large number of seats
In-depth
Healthcare
Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying
The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?
Feb 21, 2022 02:30 PM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 18, 2022 06:30 PM
Briefing Feb 04, 2022 09:09 PM
· Healthcare
New industrial orders in Germany increased month on month in December 2021
Healthcare
China's First Modified New Drug of Docetaxel Successfully Went to the US
Feb 19, 2025 10:41 AM
Briefing Jan 24, 2022 01:19 PM
· Technology
Fuman micro collapsed in the afternoon, and the stock price was close to the limit
Briefing Jan 21, 2022 12:19 PM
· Technology
Changchun hi tech: nine directors, supervisors and senior management personnel increased their holdings of 84700 shares in the company
Briefing Jan 20, 2022 04:29 PM
· Technology
Changchun hi tech fell again today, and the four institutions sold a total of 170 million yuan.
Briefing Jan 20, 2022 02:49 PM
· Technology
Consumer electronics stocks continued to decline
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth
AI · Analysis
Computing power is productivity: An infrastructure competition concerning the next ten years
May 20, 2026 11:05 AM
Insight
In-depth
Consumer Discretionary · Interview
From a "Huawei substitute" to falling out of the top five: Where exactly did Honor lose?
May 19, 2026 12:00 PM